Co-Authors
This is a "connection" page, showing publications co-authored by Iwan van der Horst and Sjoerd Timmermans.
Connection Strength
0.282
-
Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19. Circulation. 2020 11 03; 142(18):1787-1790.
Score: 0.226
-
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. Lancet Rheumatol. 2020 Dec; 2(12):e764-e773.
Score: 0.057